Source: Frontiers in Endocrinology. Unidade: FMRP
Subjects: CÉLULAS ESTROMAIS, DIABETES MELLITUS, GLICEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABOIA, Jaquellyne G. Penaforte et al. Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy. Frontiers in Endocrinology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fendo.2017.00331. Acesso em: 13 nov. 2024.APA
Saboia, J. G. P., Montenegro, R. M., Couri, C. E., Batista, L. A., Montenegro, A. P. D. R., Fernandes, V. O., et al. (2017). Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy. Frontiers in Endocrinology, 8. doi:10.3389/fendo.2017.00331NLM
Saboia JGP, Montenegro RM, Couri CE, Batista LA, Montenegro APDR, Fernandes VO, Akhtar H, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Simões BP, Gomes MB, Rodrigues MC de O. Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy [Internet]. Frontiers in Endocrinology. 2017 ; 8[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fendo.2017.00331Vancouver
Saboia JGP, Montenegro RM, Couri CE, Batista LA, Montenegro APDR, Fernandes VO, Akhtar H, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Simões BP, Gomes MB, Rodrigues MC de O. Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy [Internet]. Frontiers in Endocrinology. 2017 ; 8[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fendo.2017.00331